Top Health Tech Companies in Hyderabad (69)
Cohere Health’s clinical intelligence platform and agentic AI-powered solutions connect health plans’ strategic goals and providers’ needs, optimizing the speed, cost, and quality of care. With an enterprise approach that streamlines payer-provider decision-making across the care continuum–including policy, prior authorization, payment accuracy, and more–the company improves collaboration and reduces burden, resulting in up to 8x ROI and 94% provider satisfaction....
Cohere Health's Top Stability & Growth Strengths
Strong Revenue Growth: Revenue is reported as expanding rapidly, with more than 60% year-over-year growth in committed ARR in 2024. External recognitions like Deloitte Technology Fast 500 and repeat Inc. 5000 placements point to sustained multi-year momentum.
Market Expansion: New health plan partnerships and an increase to 17 health plans by 2026, alongside 12 million annual prior authorizations and 25M covered lives, indicate a widening commercial footprint. Integrations such as Epic’s Payer Platform and expanded relationships with national and regional plans reinforce adoption.
Investor Backing & Capital Strength: A $90 million Series C in 2025 brought total funding to roughly $200 million. Successive raises and participation from prominent investors suggest ample capital to support scaling.
Optum, part of the UnitedHealth Group family of businesses, is a global organization that delivers care, aided by technology to help millions of people live healthier lives. The work you do with our team will directly improve health outcomes by connecting people with the care, pharmacy benefits, data and resources they need to feel their best. Here, you will find...
.jpg)
Optum's Top Stability & Growth Strengths
Strong Revenue Growth: Optum’s consolidated revenue expanded from $253.0B in 2024 to $270.6B in 2025, indicating continued top-line growth. Multi‑year reporting also highlights ongoing increases at the consolidated level even as segment performance diverges.
Diversified Revenue Streams: Performance is spread across three businesses, with Optum Rx delivering substantial gains, Optum Insight growing modestly, and Optum Health contracting. This mix shows pharmacy and technology services helping sustain overall scale despite softness in care delivery.
Cost & Operational Efficiency: Operating performance improved in 2026 as Optum’s operating income rose year over year to about $4B in Q2 alongside reported gains in technology and clinical operations. UnitedHealth also raised its 2026 adjusted EPS outlook, signaling confidence in execution.
Schrödinger is a leading provider of advanced molecular simulations and enterprise software solutions and services for pharmaceutical, biotechnology, and materials science research. The predictive power of Schrödinger's software allows scientists to accelerate their research and development, reduce research costs, and make novel discoveries.
Schrödinger, Inc.'s Top Stability & Growth Strengths
Strong Revenue Growth: Recent results indicate total revenue increased year over year in 2025 and continued to rise in the latest reported quarter. Guidance and quarterly updates point to ongoing top-line expansion even as mix shifts occur.
Resilient & Sustainable Growth: Underlying annual contract value expanded and accelerated in 2026, with management indicating continued growth despite the transition to hosted licensing. This suggests the core subscription base is strengthening even when reported revenue timing varies.
Diversified Revenue Streams: Growth is visible in both the software business and the milestone-driven drug discovery segment. The latter stepped up meaningfully in recent periods, complementing steady software momentum.
ZS is a management consulting and technology firm that partners with companies to improve life and how we live it. We transform ideas into impact by bringing together data, science, technology and human ingenuity to deliver better outcomes for all. Founded in 1983, ZS has more than 15,000+ employees in over 40 offices worldwide.
ZS's Top Stability & Growth Strengths
Strong Hiring & Retention: Hiring and headcount are expanding, with disclosures of 15,000+ global employees, thousands of new hires, and third‑party estimates indicating continued workforce growth. Available evidence also points to active internal mobility and a recent increase in active job postings.
Market Expansion: Geographic and client footprints are broadening, with 40+ offices and 1,700+ customers across 170+ countries alongside concrete investments in new and expanded locations such as Hyderabad and Kingston. These moves indicate scaling delivery capacity in major capability centers and new regions.
Innovation-Driven Growth: The offering mix is shifting toward AI, data, technology, and platforms, including proprietary solutions and product capabilities. Strategic moves such as Salesforce-focused acquisitions and collaborations, plus a Tulip solution partnership, extend capabilities beyond traditional consulting.
Thryve Digital Health, with its headquarters in Chennai and another center in Hyderabad, India is one of health care’s first global development centers where 3800 best minds in health care technology, science and business create powerful and innovative solutions that transform lives. Thryve creates solutions that enable the “payvider” network with the intelligence, connectivity and seamless integration demanded by its...
Apollo Clinic is a subsidiary of Apollo Hospitals Enterprise, offering a wide range of medical services with that same trusted expertise and excellence. They aim to deliver quality healthcare of international standards to neighbourhoods across the country. Apollo Clinics are an integrated multi-speciality clinic that offers Specialist Consultation, Diagnostics, Preventive Health Checks and Pharmacy, all under one roof. With state-of-the-art...
Apollo TeleHealth is a unit of Apollo Hospitals Group. Apollo Telehealth harnesses the benefits of ICT and biomedical technology for bringing quality healthcare closer to underserved communities. It has a comprehensive e-Health solution enabling quality healthcare delivery on the cloud network. Its proven track record in implementing telemedicine turnkey solutions in strengthening public health systems is an innovation in the...
HEAPS is a pioneering care management and coordination platform that aims to deliver more efficient and effective health care through AI, data analytics and highly personalized patient-focused programs. The platform sources, analyzes and summarizes complex data points into actionable insights that help insurers and hospitals make better decisions to save more lives. Its predictive modelling system helps address patients' present...
Castlight is on a mission to make it as easy as humanly possible to navigate healthcare and live happier, healthier, more productive lives. Our health navigation platform connects with hundreds of health vendors, benefits resources, and plan designs, giving rise to the world’s first comprehensive app for all health needs. Please note that all interviews will be scheduled by direct representatives...
Sai Life Sciences is built on the bedrock of partnership. We work with innovator pharma and biotech companies to accelerate the discovery, development and manufacture of complex small molecules for a healthier tomorrow. Our Vision is to support our global innovator partners bring 25 new medicines to life by 2025. And we are well on that journey.
Zurn Elkay Water Solutions supplies the industry’s widest range of clean water solutions for drinking water, hygiene and sustainable water management. Headquartered in Milwaukee, Wisconsin, Zurn Elkay works with customers around the globe to deliver products and systems that enhance and ensure water quality, safety, hygiene, flow control and conservation. From healthcare to hospitality, education to retail and residential to...
Zurn Elkay Water Solutions's Top Stability & Growth Strengths
Strong Revenue Growth: Feedback suggests revenue is expanding across periods, with full‑year 2025 growth and Q1 2026 double‑digit core and net sales increases, alongside guidance pointing to further gains. Momentum appears broad‑based across nearly all product categories.
Profitability: Feedback suggests profitability is strengthening, with adjusted EBITDA growth, margin expansion, and higher net income and EPS. Company disclosures note a gross margin well above industry averages, supported by pricing power and operational efficiency.
Healthy Cash Flow: Feedback suggests cash generation and balance‑sheet flexibility are robust, highlighted by record free cash flow in 2025 and low net leverage around 0.5x. Expanded revolver capacity and recent buybacks indicate capacity to fund initiatives and shareholder returns.
ProPharma is the premier Research Consulting Organization (RCO), delivering fully customizable consulting solutions to empower biotech, med device, and pharmaceutical organizations of all sizes to advance scientific breakthroughs confidently and introduce new therapies. With over 20 years of expertise in regulatory sciences, clinical research solutions, quality & compliance, pharmacovigilance, medical information, and R&D technology, ProPharma partners with clients across the...
ProPharma's Top Stability & Growth Strengths
Market Expansion: Feedback suggests the company is broadening its global footprint, including opening a new office in Hyderabad and expanding across Central and Eastern Europe via acquisitions. These moves indicate a focus on scaling operations and accessing new markets.
Strategic Partnerships: Feedback suggests targeted acquisitions such as Clinres Farmacija and Digital Lab Consulting are used to enhance capabilities and geographic reach. These integrations appear to strengthen end-to-end service coverage across regulatory, clinical, and R&D functions.
Strong Brand Reputation: Feedback suggests multiple industry awards and recognitions, including CPHI and CRO Leadership distinctions, bolster standing as a top-tier provider. External analyst mentions, such as Everest Group’s PEAK Matrix designation, reinforce credibility.
Expanding on their combined 50-year history, Perceptive provides best-in-class specialist support to global pharmaceutical, biotech, and clinical research organizations, spanning the complete R&D lifecycle, from discovery and preclinical through clinical development to post marketing. Perceptive’s offerings include imaging biomarkers and core lab services, as well as innovative technologies in randomization and trial supply management (RTSM), analytics, and software.
EPAM (NYSE:EPAM) is a global leader in AI transformation engineering and integrated consulting, serving Forbes Global 2000 companies and ambitious startups. With over thirty years of expertise in custom software, product and platform engineering, EPAM empowers organizations to become AI-Native enterprises, driving measurable value from innovation and digital investments. Recognized by industry benchmarks and leading analysts as a leader in...
EPAM Systems's Top Stability & Growth Strengths
Strong Revenue Growth: Feedback suggests revenue expanded meaningfully in 2025 and continued to rise into 2026, albeit at a slower pace. Annual results indicate double-digit growth for 2025, with subsequent quarters still posting year-over-year increases.
Profitability: Feedback suggests margins and earnings improved alongside growth, with operating income and EPS rising year over year. This points to strengthening profitability even as top-line expansion moderates.
Strong Hiring & Retention: Feedback suggests headcount expanded to roughly 62,850, tracking with business demand. The increase in delivery professionals signals continued scaling of execution capacity.
Telluris Biotech India Private Limited is involved in developing solutions to important issues plaguing the agricultural and food processing industries.
As a strategic partner to some of the world’s largest healthcare organizations, we play a deep and meaningful role in accelerating digital innovation, driving sustainable value and helping improve outcomes across the healthcare ecosystem. With our deep healthcare domain knowledge and next-generation technology focus, we are well positioned to build digital capabilities and specialized platforms, enabling healthcare organizations reinvent themselves...
R1 is a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers R1’s proven and scalable operating models seamlessly complement a healthcare organization’s infrastructure, quickly driving sustainable improvements to net patient revenue and cash flows while reducing operating costs and enhancing the patient experience.
R1 RCM's Top Stability & Growth Strengths
Strong Revenue Growth: Revenue is described as rising across recent years and quarters, supported by new long‑term contracts, acquisitions, and expanding client deployments. Technology‑enabled offerings and growing demand for outsourced RCM are cited as tailwinds.
Strong Market Position & Advantage: The company is presented as a category leader with an extensive client base that includes a large share of top U.S. health systems and repeated top rankings in ambulatory services. Its end‑to‑end platform and scale are highlighted as differentiators.
Investor Backing & Capital Strength: An $8.9B take‑private by TowerBrook and CD&R is framed as providing resources for innovation and expansion. The transaction is described as validating market standing and future growth potential.
Knack RCM empowers leading healthcare delivery organizations with end-to-end revenue cycle services that generate efficiencies, accelerate payments, and deliver operational insights, freeing caregivers to focus on high-quality patient care. Knack’s expertise was developed over nearly 20 years of serving a broad range of healthcare providers in a variety of formats including hospital/physician groups, durable medical equipment suppliers, surgical and ambulatory care...
The idea of Yashoda Hospitals was born in the heart of Dr G Surender Rao, one of Hyderabad's eminent clinicians. In 1985, after an international education in medicine, he returned to India and set up a professional practice. In the next few years his practice flourished but he became increasingly frustrated by the lack of adequate hospital infrastructure for his...
We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and...
Sanofi's Top Stability & Growth Strengths
Strong Revenue Growth: Sales growth is described as strong, with 2025 net sales up at constant exchange rates and Q4 showing further acceleration, indicating momentum into 2026.
Profitability: Earnings expansion is described as outpacing sales growth in 2025, and 2026 guidance indicates continued profitable expansion with EPS growing slightly faster than sales.
Product Line Growth: Newer launches are scaling rapidly, with notable growth in recent pharma launches and contributions from products beyond the flagship franchise, helping broaden growth drivers.
